In addition, decreased expression and promoter hypermethylation of DACT1 and DACT2 have been found in some primary tumors and tumor cell lines, including hepatocellular carcinoma [15], breast cancer [16], lung cancer [17], colorectal cancer [18] and some other cancers. This evidence concerns the gene DACT2 and cancer.